%0 Journal Article
%T Ceritinib as a promising therapy for ALK related diseases
%A Monica Ceccon
%J SCIE-indexed Journal
%D 2014
%X The journal article ˇ°Ceritinib in ALK-rearranged non-small-cell lung cancerˇ±, published last 27th of March on the New England Journal of Medicine (N Engl J Med), reports for the first time the clinical data from the phase 1 study on the anaplastic lymphoma kinase (ALK) inhibitor ceritinib, also known as LDK-378 (Novartis)
%U http://tlcr.amegroups.com/article/view/2976/4016